Aches - Pains
- Manufacturer
- Newton Laboratories, Inc.
- Effective date
- 2011-03-01
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:39:35
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
Aches - Pains Formulated for symptoms associated with bruises, strains and overexertion such as pain, stiffness and inflammation.
DOSAGE & ADMINISTRATION SECTION
Directions: Ages 12 and up, take 6 pellets orally (ages 0 to 11, give 3 pellets) as needed or as directed by a healthcare professional. Under age 2, crush or dissolve pellets in purfied water. Sensitive persons begin with 1 pellet and gradually increase to full dose.
OTC - ACTIVE INGREDIENT SECTION
Aconitum nap. 15x, Arg. nit. 15x, Arnica 15x, Bryonia 15x, Colchicum 15x, Guaiacum 15x, Hypericum 15x, Kalmia latifolia 15x, Phosphorus 15x, Phytolacca 15x, Pulsatilla 15x, Rhus toxicodendron 15x, Ruta 15x, Sarcolacticum ac. 15x, Sticta 15x, Stramonium 15x, Hamamelis 3x, Phytolacca 3x, Ruta 3x, Taraxacum 3x.
OTC - PURPOSE SECTION
Formulated for symptoms associated with bruises, strains and overexertion such as pain, stiffness and inflammation.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.
OTC - QUESTIONS SECTION
www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256
WARNINGS SECTION
Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.
OTC - PREGNANCY OR BREAST FEEDING SECTION
Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
PACKAGE LABEL
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Aconitum Napellus | ACTIVE INGREDIENT | U0NQ8555JD | 2 | |
| Arnica Montana | ACTIVE INGREDIENT | O80TY208ZW | 2 | |
| Bryonia Alba Root | ACTIVE INGREDIENT | T7J046YI2B | 2 | |
| Colchicum Autumnale Bulb | ACTIVE INGREDIENT | 993QHL78E6 | 2 | |
| Datura Stramonium | ACTIVE INGREDIENT | G6W4F0V8Z3 | 2 | |
| Guaiac | ACTIVE INGREDIENT | 03C8A0DFJ8 | 2 | |
| Hamamelis Virginiana Root Bark/stem Bark | ACTIVE INGREDIENT | T7S323PKJS | 2 | |
| Hypericum Perforatum | ACTIVE INGREDIENT | XK4IUX8MNB | 2 | |
| Kalmia Latifolia Leaf | ACTIVE INGREDIENT | 79N6542N18 | 2 | |
| Lactic Acid, L- | ACTIVE INGREDIENT | F9S9FFU82N | 2 | |
| Lobaria Pulmonaria | ACTIVE INGREDIENT | D1YM0P5Z2T | 2 | |
| Phosphorus | ACTIVE INGREDIENT | 27YLU75U4W | 2 | |
| Phytolacca Americana Root | ACTIVE INGREDIENT | 11E6VI8VEG | 2 | |
| Pulsatilla Vulgaris | ACTIVE INGREDIENT | I76KB35JEV | 2 | |
| Ruta Graveolens Flowering Top | ACTIVE INGREDIENT | N94C2U587S | 2 | |
| Silver Nitrate | ACTIVE INGREDIENT | 95IT3W8JZE | 2 | |
| Taraxacum Officinale | ACTIVE INGREDIENT | 39981FM375 | 2 | |
| Toxicodendron Pubescens Leaf | ACTIVE INGREDIENT | 6IO182RP7A | 2 | |
| Aconitum Napellus | ACTIVE MOIETY | U0NQ8555JD | 2 | |
| Arnica Montana | ACTIVE MOIETY | O80TY208ZW | 2 | |
| Bryonia Alba Root | ACTIVE MOIETY | T7J046YI2B | 2 | |
| Colchicum Autumnale Bulb | ACTIVE MOIETY | 993QHL78E6 | 2 | |
| Datura Stramonium | ACTIVE MOIETY | G6W4F0V8Z3 | 2 | |
| Guaiac | ACTIVE MOIETY | 03C8A0DFJ8 | 2 | |
| Hamamelis Virginiana Root Bark/stem Bark | ACTIVE MOIETY | T7S323PKJS | 2 | |
| Hypericum Perforatum | ACTIVE MOIETY | XK4IUX8MNB | 2 | |
| Kalmia Latifolia Leaf | ACTIVE MOIETY | 79N6542N18 | 2 | |
| Lactic Acid, L- | ACTIVE MOIETY | F9S9FFU82N | 2 | |
| Lobaria Pulmonaria | ACTIVE MOIETY | D1YM0P5Z2T | 2 | |
| Phosphorus | ACTIVE MOIETY | 27YLU75U4W | 2 | |
| Phytolacca Americana Root | ACTIVE MOIETY | 11E6VI8VEG | 2 | |
| Pulsatilla Vulgaris | ACTIVE MOIETY | I76KB35JEV | 2 | |
| Ruta Graveolens Flowering Top | ACTIVE MOIETY | N94C2U587S | 2 | |
| Silver Cation | ACTIVE MOIETY | 57N7B0K90A | 2 | |
| Taraxacum Officinale | ACTIVE MOIETY | 39981FM375 | 2 | |
| Toxicodendron Pubescens Leaf | ACTIVE MOIETY | 6IO182RP7A | 2 | |
| Sucrose | INACTIVE INGREDIENT | C151H8M554 | 2 |
Products#
Every source-derived product name is available through these pages.
- Aches - Pains
- Aconitum nap., Arg. nit., Arnica, Bryonia, Colchicum, Guaiacum, Hypericum, Kalmia, Phosphorus, Phytolacca, Pulsatilla, Rhus toxicodendron, Ruta, Sarcolacticum ac., Sticta, Stramonium, Hamamelis, Taraxacum,
- Aconitum Napellus
- Silver Nitrate
- Silver Cation
- Arnica Montana
- Bryonia Alba Root
- Colchicum Autumnale Bulb
- Guaiac
- Hypericum Perforatum
- Kalmia Latifolia Leaf
- Phosphorus
- Phytolacca Americana Root
- Pulsatilla Vulgaris
- Toxicodendron Pubescens Leaf
- Ruta Graveolens Flowering Top
- Lactic Acid, L-
- Lobaria Pulmonaria
- Datura Stramonium
- Hamamelis Virginiana Root Bark/stem Bark
- Taraxacum Officinale
- Sucrose
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55714-2237 | 55714-2237-1, 55714-2237-2, 55714-2237-0 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / SUBLINGUAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / SUBCUTANEOUS | 47.75 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 308 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUPPOSITORY / RECTAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / TRANSMUCOSAL | 1255 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 900 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / BUCCAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, EMULSION / INTRAVENOUS | 970 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / INTRAVENOUS | 1950 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 7560 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| Sucrose | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 9.4 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 1 mg | ||
| Sucrose | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| Sucrose | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION/ DROPS / ORAL | 3750 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 97e09184-71a8-136d-e053-2995a90a84a4 | 09fbdfb3-086b-d01a-1da1-3fb2bf8c7ba0 | 2019-11-21 | Warnings | 09fbdfb3-086b-d01a-1da1-3fb2bf8c7ba0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
